System Labs GLP-1 prices
Online telehealth company (System Laboratories, Inc., San Francisco) selling compounded tirzepatide with vitamin B3 at one flat monthly price at all doses, alongside peptide therapies such as MIC+B12 (compounded, not FDA-approved). System Labs has 1 sourced self-pay GLP-1 offer here. Advertised entry prices: Compounded tirzepatide $179/mo. Plan terms, fees and the check date are listed with each quote.
BBB FIs System Labs legit?How to cancel System LabsCheaper alternativesCurrent sale
System Labs: prices at a glance
Compounded, not FDA-approved
Compounded tirzepatide
$179/mo
Search by medication, provider or treatment goal. Examples follow.
1 offers · US self-pay · 1 maintenance quotes
This order ignores commission. Partner links may earn us a referral fee.
- Advertised price$179/mo
Supply period unverified; excluded from cost ranking.
Checked
Maintenance price$179/moView offerAt 15 mg
Supply period unverified; excluded from cost ranking.
Checked
Price conditions & source
Advertised price: monthly subscription, $99 the first month, then a flat $179 a month; the same price at all doses ("Monthly Supply (All doses)"); injection supplies and 2-day temperature-controlled shipping included
Maintenance terms: The seller states one price at every dose, so this is also its price at 15 mg.
System Labs sells this as "Compounded GLP-1/GIP"; its intake page names the medication as tirzepatide with vitamin B3. It says "billed at a flat $179/mo with no hidden fees", with automatic refills and "pause or cancel anytime" from the dashboard. Its terms allow no refund once medication has shipped. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source (systemlabs.com)
Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.
Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.
The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of October 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.
System Labs GLP-1 cost: common questions
How much does tirzepatide cost through System Labs?
Compounded tirzepatide: $179/mo (monthly subscription, $99 the first month, then a flat $179 a month; the same price at all doses ("Monthly Supply (All doses)"); injection supplies and 2-day temperature-controlled shipping included). Checked Nov 6, 2026; each quote names its source in the table. Compounded tirzepatide is not an FDA-approved product.
Does System Labs offer FDA-approved GLP-1 medication or compounded versions?
The System Labs offers tracked here are compounded: Compounded tirzepatide. Compounded GLP-1s are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality.
Does System Labs charge a membership fee?
No membership fee is charged beside the price: System Labs's own pages say the price includes the clinician's care with the medication, for Compounded tirzepatide.
When were System Labs prices last checked?
Each quote carries its own check date and links the page it was read from: Nov 6, 2026 for the offers here. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.
Does System Labs have a promo code or sale right now?
System Labs's own page states: "$99 /first mo.". Read Nov 6, 2026; we do not test codes at checkout. GLP-1 deals and promo codes at every seller
What pharmacy does System Labs use?
System Labs's pages we read name no pharmacy. In its words: "Every System formulation is compounded at a licensed U.S. pharmacy and reviewed by a licensed clinician before approval." Read Nov 6, 2026.
Are you System Labs? See how sellers are listed, how to correct a price, and the badge listed sellers can show.